Published in J Bacteriol on July 01, 1995
Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A (1998) 3.04
CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest (2007) 2.44
Uncoiling mechanics of Escherichia coli type I fimbriae are optimized for catch bonds. PLoS Biol (2006) 2.00
Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol (2006) 1.82
Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence. Infect Immun (2001) 1.56
Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci U S A (2009) 1.56
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific. J Infect Dis (2012) 1.48
Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun (2006) 1.45
Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med (2013) 1.38
Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic (2005) 1.35
Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin. Infect Immun (2007) 1.35
Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun (2006) 1.32
Haplotype diversity in "source-sink" dynamics of Escherichia coli urovirulence. J Mol Evol (2006) 1.29
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. Mol Microbiol (2006) 1.28
The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates. Infect Immun (2003) 1.18
Functional flexibility of the FimH adhesin: insights from a random mutant library. Infect Immun (2000) 1.18
Characterization of the type 3 fimbrial adhesins of Klebsiella strains. Infect Immun (1998) 1.17
Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun (2007) 1.12
Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract. Infect Immun (2008) 1.07
The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae. BMC Gastroenterol (2009) 1.06
Adaptive mutations in the signal peptide of the type 1 fimbrial adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2008) 1.00
Donor strand exchange and conformational changes during E. coli fimbrial formation. J Struct Biol (2010) 0.99
Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli. Infect Immun (2011) 0.99
Evolution of Salmonella enterica virulence via point mutations in the fimbrial adhesin. PLoS Pathog (2012) 0.98
Comparative structure-function analysis of mannose-specific FimH adhesins from Klebsiella pneumoniae and Escherichia coli. J Bacteriol (2009) 0.96
Increased type 1 fimbrial expression among commensal Escherichia coli isolates in the murine cecum following catabolic stress. Infect Immun (1999) 0.96
Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog (2013) 0.92
Identification of a Klebsiella pneumoniae strain associated with nosocomial urinary tract infection. J Clin Microbiol (1997) 0.92
Population variability of the FimH type 1 fimbrial adhesin in Klebsiella pneumoniae. J Bacteriol (2009) 0.91
Population structure of gut Escherichia coli and its role in development of extra-intestinal infections. Iran J Microbiol (2010) 0.91
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun (2012) 0.90
Shear-stabilized rolling behavior of E. coli examined with simulations. Biophys J (2010) 0.90
Characterization of 17 chaperone-usher fimbriae encoded by Proteus mirabilis reveals strong conservation. J Med Microbiol (2014) 0.90
Heterobinary adhesins based on the Escherichia coli FimH fimbrial protein. Appl Environ Microbiol (1998) 0.88
Dissection of the role of pili and type 2 and 3 secretion systems in adherence and biofilm formation of an atypical enteropathogenic Escherichia coli strain. Infect Immun (2013) 0.88
Genetic characterization of Escherichia coli type 1 pilus adhesin mutants and identification of a novel binding phenotype. J Bacteriol (2000) 0.87
Allosteric catch bond properties of the FimH adhesin from Salmonella enterica serovar Typhimurium. J Biol Chem (2011) 0.85
N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases. Glycoconj J (2005) 0.84
Novel aggregative adherence fimbria variant of enteroaggregative Escherichia coli. Infect Immun (2015) 0.82
Catch-bond mechanism of the bacterial adhesin FimH. Nat Commun (2016) 0.82
Inactive conformation enhances binding function in physiological conditions. Proc Natl Acad Sci U S A (2015) 0.81
Allosteric coupling in the bacterial adhesive protein FimH. J Biol Chem (2013) 0.81
Yielding elastic tethers stabilize robust cell adhesion. PLoS Comput Biol (2014) 0.80
Evolutionary analysis points to divergent physiological roles of type 1 fimbriae in Salmonella and Escherichia coli. MBio (2013) 0.78
Adherence and invasion of mouse-adapted H pylori in different epithelial cell lines. World J Gastroenterol (2007) 0.78
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr (2016) 0.77
Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli. Sci Rep (2015) 0.76
How type 1 fimbriae help Escherichia coli to evade extracellular antibiotics. Sci Rep (2016) 0.75
The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone. BMC Microbiol (2017) 0.75
Microelectrode array biosensor for studying carbohydrate-mediated interactions. Biosens Bioelectron (2012) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria. Trans N Y Acad Sci (1965) 20.37
Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis (1981) 14.19
Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun (1981) 14.05
Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature (1977) 10.17
Non-flagellar filamentous appendages (fimbriae) and haemagglutinating activity in Bacterium coli. J Pathol Bacteriol (1955) 9.46
Non-flagellar appendages of bacteria. Nature (1959) 7.49
An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A (1985) 6.00
Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun (1978) 5.99
Organization and expression of genes responsible for type 1 piliation in Escherichia coli. J Bacteriol (1984) 5.83
Inhibition of the interaction between fimbrial haemagglutinins and erythrocytes by D-mannose and other carbohydrates. J Gen Microbiol (1972) 4.97
Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol Gen Genet (1987) 3.59
Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun (1990) 2.94
The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit. J Bacteriol (1986) 2.93
Identification and characterization of genes determining receptor binding and pilus length of Escherichia coli type 1 pili. J Bacteriol (1987) 2.83
The fim genes responsible for synthesis of type 1 fimbriae in Escherichia coli, cloning and genetic organization. Mol Gen Genet (1985) 2.72
Identification and characterization of E. coli type-1 pilus tip adhesion protein. Nature (1988) 2.71
Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants. Mol Microbiol (1991) 2.47
Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol (1987) 2.26
Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature (1988) 2.24
Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol (1991) 2.17
Carbohydrate specificity of the surface lectins of Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium. Carbohydr Res (1983) 2.14
FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol (1994) 2.01
Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia. Clin Infect Dis (1993) 1.92
Adherent interactions which may affect microbial ecology in the mouth. J Dent Res (1984) 1.87
Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. J Biol Chem (1993) 1.49
Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infect Immun (1987) 1.41
Purification of the Escherichia coli type 1 pilin and minor pilus proteins and partial characterization of the adhesin protein. J Bacteriol (1988) 1.39
Distribution of the P-associated-pilus (pap) region among Escherichia coli from natural sources: evidence for horizontal gene transfer. Infect Immun (1989) 1.38
Escherichia coli F-18 phase locked 'on' for expression of type 1 fimbriae is a poor colonizer of the streptomycin-treated mouse large intestine. Microb Pathog (1993) 1.30
Regulation of the phase switch controlling expression of type 1 fimbriae in Escherichia coli. Mol Microbiol (1989) 1.26
Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli. J Infect Dis (1990) 1.24
Reciprocal exchange of minor components of type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities. J Bacteriol (1994) 1.23
Escherichia coli in fecal flora of healthy adults: serotypes, P and type 1C fimbriae, non-P mannose-resistant adhesins, and hemolytic activity. J Infect Dis (1992) 1.14
Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins. Infect Immun (1994) 1.13
Isolation and characterization of mutants with lesions affecting pellicle formation and erythrocyte agglutination by type 1 piliated Escherichia coli. J Bacteriol (1990) 1.11
Special virulence of the Escherichia coli O1:K1:H7 clone in acute pyelonephritis. J Pediatr (1989) 1.05
Bacterial adhesion measured by growth of adherent organisms. Methods Enzymol (1995) 0.98
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet (1982) 3.39
An international outbreak of Salmonella infections caused by alfalfa sprouts grown from contaminated seeds. J Infect Dis (1997) 3.39
Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A (1998) 3.04
Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol (1999) 2.33
Multiple adhesins of streptococci. Infect Immun (1992) 2.30
Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol (1999) 2.24
Colonial morphology of staphylococci on Memphis agar: phase variation of slime production, resistance to beta-lactam antibiotics, and virulence. J Infect Dis (1990) 2.17
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis (1996) 2.15
Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci. Infect Immun (1994) 2.15
Molecular epidemiology of an outbreak of febrile gastroenteritis caused by Listeria monocytogenes in cold-smoked rainbow trout. J Clin Microbiol (1999) 2.11
FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol (1994) 2.01
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. J Exp Med (1983) 1.96
Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity (1995) 1.85
Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet (1991) 1.82
Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J Clin Microbiol (2001) 1.81
Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis (2001) 1.78
Adherence of Streptococcus sanguis to conformationally specific determinants in fibronectin. Infect Immun (1988) 1.77
Freeze-fracture studies of the developing cell surface. II. Particle-free membrane blisters on glutaraldehyde-fixed corneal fibroblasts are artefacts. J Cell Biol (1978) 1.76
Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells. J Biol Chem (1997) 1.72
Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun (1985) 1.71
Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin. J Bacteriol (1983) 1.63
Enzyme-linked immunosorbent assay for adherence of bacteria to animal cells. J Clin Microbiol (1986) 1.62
Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes. Mol Microbiol (1999) 1.61
Binding of Streptococcus pyogenes to soluble and insoluble fibronectin. Infect Immun (1986) 1.58
Linker insertion analysis of the FimH adhesin of type 1 fimbriae in an Escherichia coli fimH-null background. FEMS Microbiol Lett (1996) 1.54
Recurrent urinary tract infections in infancy: relapses or reinfections? J Infect Dis (2002) 1.54
In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials (2006) 1.53
Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med (1982) 1.53
Interaction of human plasma fibronectin with cariogenic and non-cariogenic oral streptococci. Infect Immun (1983) 1.53
Salmonella in alfalfa sprouts. Lancet (1995) 1.52
Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem (1980) 1.50
Epidemiology and diagnosis of Mycobacterium tuberculosis in captive Asian elephants (Elephas maximus). J Zoo Wildl Med (2001) 1.49
Interactions of fibronectin with streptococci: the role of fibronectin as a receptor for Streptococcus pyogenes. Rev Infect Dis (1988) 1.46
Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis (1987) 1.44
New protective antigen of group A streptococci. J Clin Invest (1999) 1.39
Hepatic arteritis in Behçet's disease. J Rheumatol (1989) 1.39
Shiga toxin-producing Escherichia coli in finland from 1990 through 1997: prevalence and characteristics of isolates. J Clin Microbiol (1998) 1.39
Fragmentation of Escherichia coli type 1 fimbriae exposes cryptic D-mannose-binding sites. J Bacteriol (1991) 1.38
Effect of transport medium on recovery of Aeromonas species in intestinal infections. Eur J Clin Microbiol Infect Dis (1990) 1.38
Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38
Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem (2000) 1.38
Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J Immunol (1992) 1.38
matB, a common fimbrillin gene of Escherichia coli, expressed in a genetically conserved, virulent clonal group. J Bacteriol (2001) 1.35
Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect Immun (1992) 1.31
Ribotyping as an epidemiologic tool for Escherichia coli. Epidemiol Infect (1994) 1.30
Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis (1990) 1.29
Bacteriology of histopathologically defined appendicitis in children. Pediatr Infect Dis J (2000) 1.28
Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of omega-interposon mutagenesis. Infect Immun (1994) 1.28
An outbreak of Listeria monocytogenes serotype 3a infections from butter in Finland. J Infect Dis (2000) 1.27
Multiple outbreaks of Yersinia pseudotuberculosis infections in Finland. J Clin Microbiol (2004) 1.26
Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a. Infect Immun (1993) 1.25
Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun (1992) 1.25
Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997. J Antimicrob Chemother (1999) 1.24
Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group. J Infect Dis (1992) 1.22
Distribution of molecular subtypes within Salmonella enterica serotype Enteritidis phage type 4 and S. Typhimurium definitive phage type 104 in nine European countries, 2000-2004: results of an international multi-centre study. Epidemiol Infect (2006) 1.20
Lipoteichoic acid and M protein: dual adhesins of group A streptococci. Microb Pathog (1992) 1.20
Relationship of critical micelle concentrations of bacterial lipoteichoic acids to biological activities. Infect Immun (1986) 1.19
Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19
Isolation and characterization of a 60-kilodalton salivary glycoprotein with agglutinating activity against strains of Streptococcus mutans. Infect Immun (1986) 1.19
Oat beta-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains. Appl Microbiol Biotechnol (1998) 1.19
Association of Aeromonas spp. with travellers' diarrhoea in Finland. J Med Microbiol (1995) 1.18
Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H- human isolates from Finland. Clin Microbiol Infect (2006) 1.18
Binding of fibronectin to human buccal epithelial cells inhibits the binding of type 1 fimbriated Escherichia coli. Infect Immun (1985) 1.17
Aggregation of group A streptococci by human saliva and effect of saliva on streptococcal adherence to host cells. Infect Immun (1991) 1.16
Bacterial adherence: the attachment of group A streptococci to mucosal surfaces. Rev Infect Dis (1988) 1.16
Characterization of Hafnia alvei by biochemical tests, random amplified polymorphic DNA PCR, and partial sequencing of 16S rRNA gene. J Clin Microbiol (1995) 1.15
Salmonella enteritidis phage types 1 and 4: pheno- and genotypic epidemiology of recent outbreaks in Finland. J Clin Microbiol (1999) 1.15
Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis (1993) 1.15
Freeze-fracture studies of the developing cell surface. I. The plasmalemma of the corneal fibroblast. J Cell Biol (1977) 1.14
Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M proteins. J Immunol (1989) 1.12
Distribution of Aeromonas phenospecies and genospecies among strains isolated from water, foods or from human clinical samples. Epidemiol Infect (1995) 1.11
New 16-plex PCR method for rapid detection of diarrheagenic Escherichia coli directly from stool samples. Eur J Clin Microbiol Infect Dis (2009) 1.09
Hafnia alvei in stool specimens from patients with diarrhea and healthy controls. J Clin Microbiol (1994) 1.08
A 28-kilodalton fibronectin-binding protein of group A streptococci. Curr Microbiol (1992) 1.08
Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis (2004) 1.07
Surveillance of listeriosis in Finland during 1995-2004. Euro Surveill (2006) 1.06
Molecular epidemiology of an outbreak caused by Salmonella enterica serovar Newport in Finland and the United Kingdom. Epidemiol Infect (2000) 1.05
Yersinia pseudotuberculosis causing a large outbreak associated with carrots in Finland, 2006. Epidemiol Infect (2009) 1.05
Release of fibronectin-lipoteichoic acid complexes from group A streptococci with penicillin. Infect Immun (1986) 1.05
Swimming-associated outbreak of Escherichia coli O157:H7. Epidemiol Infect (1999) 1.04
Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos. Med Microbiol Immunol (1996) 1.04
Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid. J Infect Dis (1994) 1.03
Molecular epidemiology of two international sprout-borne Salmonella outbreaks. J Clin Microbiol (1997) 1.02
Relationship of pulsed-field profiles with key phage types of Salmonella enterica serotype Enteritidis in Europe: results of an international multi-centre study. Epidemiol Infect (2007) 1.02
The role of pili in the adhesion of Escherichia coli to human urinary tract epithelial cells. Scand J Infect Dis Suppl (1982) 1.01
Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scand J Infect Dis (2000) 1.01
EPEC, EAEC and STEC in stool specimens: prevalence and molecular epidemiology of isolates. Diagn Microbiol Infect Dis (2001) 0.99
Fine structure of collagens and their relation to glucosaminoglycans (GAG). Suppl Thromb Haemost (1978) 0.99
Phage types and genotypes of Shiga toxin-Producing Escherichia coli O157 in Finland. J Clin Microbiol (2001) 0.99
Prevalence of diarrheagenic Escherichia coli in finns with or without diarrhea during a round-the-world trip. J Clin Microbiol (2000) 0.99
Bacterial adhesion measured by growth of adherent organisms. Methods Enzymol (1995) 0.98